Home » Topics » BioWorld Science

BioWorld Science
RSS

Sativex improves spasticity in MS patients in phase III trial

June 23, 2004

European approval for Watson's oxybutynin transdermal product

June 23, 2004

Phase I trial for Pevion's new malaria vaccine

June 23, 2004

Novel glycogen phosphorylase inhibitors under study at Pfizer

June 23, 2004

New iNOS inhibitors claimed for use in arthritis, IBD, pain, etc.

June 23, 2004

Four series of chemokine CCR2 modulators and their use in arthritis and other disorders

June 23, 2004

5-HT reuptake inhibitors and 5-HT receptor agonists developed at Merck KGaA

June 23, 2004

Novel GABA-A receptor ligands in early development at Neurogen

June 23, 2004

Another series of antibacterial aminopeptidase inhibitors reported by Procter & Gamble

June 23, 2004

New antimicrobial cephems described by Fuijsawa and Wakunaga scientists

June 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...